⌘K
t
Halma plc issued an update statement on 17 January 2022 regarding its Annual General Meeting held on 22 July 2021. At the AGM, 92.88% of votes were cast in favour of Resolution 3 (Directors' Remuneration Report) and 60.18% in favour of Resolution 4 (Directors' Remuneration Policy). Following more than 20% of votes against Resolution 4, Halma engaged with shareholders, who provided feedback requesting additional clarity on the chosen benchmark in the 2022 Directors' Remuneration Report.
| Date | 17 Jan 2022 |
| Time | 07:00:06 |
| Category | AGMs and other meetings |
| ID | 5315Y |
Halma plc ('Halma')
2021 Annual General Meeting - Voting Results Update Statement
At the Company's Annual General Meeting ("AGM") held on 22 July 2021, the total votes received in favour of remuneration-related resolutions were 92.88% (Resolution 3 - Directors' Remuneration Report) and 60.18% (Resolution 4 - Directors' Remuneration Policy).
Given more than 20 per cent of votes were cast against Resolution 4, Halma is providing an update on the views received from shareholders and actions taken as set out under the provisions of the UK Corporate Governance Code.
Apart from feedback on the need to provide additional clarity on the chosen benchmark in the 2022 Directors' Remuneration Report, no new concerns were raised during the engagement process.
In line with our normal practice the Board will continue to engage with shareholders and their representative bodies and will provide a final update in the 2022 Directors' Remuneration Report.
|
For further information, please contact: |
|
|
|
|
|
Mark Jenkins Company Secretary, Halma plc Tel: +44 (0)1494 721111 |
|
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.
Its purpose defines the three broad market areas where it operates:
· Safety: protecting life as populations grow and protecting worker safety.
· Environment: improving food and water quality, and monitoring air pollution.
· Health: meeting rising healthcare demand as growing populations age and lifestyles change.
It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.
In January 2021, Halma was named Britain's Most Admired Company by Management Today.